Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction Study of S-309309 and Itraconazole
NCT06106334Phase 1Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Nov 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of S-309309 in obesity, sponsored by Shionogi & Co., Ltd. Primary endpoints: Area Under the Concentration-Time Curve Extrapolated From Time 0 to Infinity at Day 19, Area Under the Concentration-Time Curve Extrapolated From Time 0 to the Time of the Last Quantifiable Concentration at Day 19 and 1 more. Started Nov 2023; status: completed.
02
Drugs
S-309309
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06106334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06106334.